NOUMED TOPIRAMATE topiramate 200 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

noumed topiramate topiramate 200 mg tablet bottle

avallon pharmaceuticals pty ltd - topiramate, quantity: 200 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

NEBILET  nebivolol (as hydrochloride) 1.25 mg/5 mg composite starter titration tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

nebilet nebivolol (as hydrochloride) 1.25 mg/5 mg composite starter titration tablet blister pack

a menarini australia pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: microcrystalline cellulose; polysorbate 80; maize starch; croscarmellose sodium; hypromellose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - nebivolol is indicated: to treat essential hypertension; to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

C-FLOX 250 ciprofloxacin 250mg (as hydrochloride) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

c-flox 250 ciprofloxacin 250mg (as hydrochloride) tablet blister pack

alphapharm pty ltd - ciprofloxacin hydrochloride, quantity: 277.5 mg (equivalent: ciprofloxacin, qty 250 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; maize starch; crospovidone; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 8000; triacetin; polydextrose - for the treatment of infections caused by susceptible organisms in the following conditions: - urinary tract infections - gonorrhoeal urethritis and cervicitis - gastroenteritis - bronchial infections - skin and skin structure infections - bone and joint infections - chronic bacterial prostatitis of mild to moderate severity.- inhalational anthrax (post-exposure). to reduce the incidence or progression of disease following exposure to aerosolised bacillus anthracis. ciprofloxacin serum concentrations achieved in humans serve as a surrogate endpoint reasonably likely to predict clinical benefit and provide the basis for this indication. note:1. typhoid and paratyphoid infections and infections due to multi-resistant staphylococcus aureus are excluded from the above due to insufficient data. 2. because gram-positive organisms are generally less sensitive to ciprofloxacin, it may not be the drug of choice in case with gram-positive infections, such as pneumonia due to streptococcus pneumoniae. 3. chronic bacterial prostatitis should be demonstrated by microbiological evidence localising infection to the prostate. strains of neisseria gonorrhoea resistant to ciprofloxacin have been reported in australia. appropriate culture and susceptibility tests should be performed before treatment in order to determine organism susceptibility to ciprofloxacin and after treatment as warranted by the clinical condition. therapy with ciprofloxacin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. c-flox is suitable to treat mixed infections caused by susceptible strains of both gram-negative and gram-positive aerobic bacteria. if anaerobic organisms are suspected as accompanying aetiological agents, additional therapy should be considered. consideration should be given to available official guidance on the appropriate use of antibacterial agents.

ALPHAPRESS 50 hydralazine hydrochloride 50 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alphapress 50 hydralazine hydrochloride 50 mg tablet bottle

alphapharm pty ltd - hydralazine hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; purified talc; disodium edetate; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; iron oxide yellow; macrogol 4000; erythrosine - this product accepted for registration as 'currently supplied' at the time of commencement of the act. amended product information (variation to pregnancy statement) was approved as specified in the letter of 13 august 92 from dr bijoy varma. indications as at 28 november 2001 : hypertension (drug resistant, moderate to severe): as supplementary medication for use together with other antihypertensives such as "beta"-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.

HYDRAVOL IV- hydroxyethyl starch, sodium chloride injection, solution United States - English - NLM (National Library of Medicine)

hydravol iv- hydroxyethyl starch, sodium chloride injection, solution

vedco, inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58) - hydravol iv™ acts as plasma volume substitute for the treatment and prophylaxis of hypovolemia. it is not a substitute for red blood cells or coagulation factors in plasma. the use of hydravol iv™ is contraindicated in the following conditions: - known hypersensitivity to hydroxyethyl starch. - fluid overload (hyperhydration) and especially in cases of pulmonary edema and congestive heart failure. - renal failure with oliguria or anuria not related to hypovolemia. - patients receiving dialysis treatment. - severe hypernatremia or severe hyperchloremia. - intracranial bleeding.

Ardo Amelie Star Infant Incubator Singapore - English - HSA (Health Sciences Authority)

ardo amelie star infant incubator

star medical co pte ltd - general hospital - intended for therapy and care of neonates in a medical environment.

WHITESTAR CLOPYRALID 300 HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

whitestar clopyralid 300 herbicide

agricultural product services pty ltd - clopyralid - soluble concentrate - clopyralid pyridine active 300.0 g/l - herbicide - barley - prior to sowing | barley - see label | canola - see label | fallow land - post emergence weed contro | forest - post em - californian thistle | cape ivy | capeweed | creeping/russian knapweed,hardhead | groundsel | nodding thistle | prickly lettuce | saffron thistle | scotch thistle | silver wattle | skeleton weed | slender, shore or sheep thistle | soldier thistle | spear or black thistle | stemless thistle | variegated thistle | volunteer chickpea | volunteer faba bean | volunteer field pea | volunteer lentil | volunteer lucerne - seedling | volunteer lupin | volunteer medic | volunteer safflower | volunteer subterranean clover | volunteer vetch or tares | blessed thistle | bull thistle | cabbage thistle | canada thistle | carduus marianus | common lucerne | cotton thistle | creeping thistle | false star thistle | field pea | hardhead thistle | heraldic thistle | holy thistle | lady's thistle | lentil | milk thistle | musk thistle | perennial thistle | picnomom acarna | senecio vulgaris | shore thistle | slender thistle | spear thistle | spotted thistle | st mary's thistle | stinging californian thistle | true scotch thistle |

WHITESTAR CLOPYRALID 750SG HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

whitestar clopyralid 750sg herbicide

agricultural product services pty ltd - clopyralid present as the potassium salt - water soluble granules - clopyralid present as the potassium salt pyridine active 750.0 g/kg - herbicide - canola - post emergence | canola - post sowing/pre-emergence | canola (prior to sowing) | canola-triazine tolerant only-post eme - californian thistle | capeweed | common cotula or carrot weed | cotulas | creeping/russian knapweed,hardhead | lucerne | nodding thistle | prickly lettuce | saffron thistle | scotch thistle | skeleton weed | slender, shore or sheep thistle | soldier thistle | sow or milk thistle | spear or black thistle | st barnaby's thistle | stemless thistle | subterranean clover | thistle | variegated thistle | vetches | volunteer canola | volunteer chickpea | volunteer faba bean | volunteer field pea | volunteer lentil | volunteer lucerne - seedling | volunteer lupin | volunteer medic | volunteer medic - seedling | volunteer safflower | volunteer subterranean clover | volunteer vetch or tares | bird's eye | blessed thistle | bull thistle | cabbage thistle | canada thistle | carduus marianus | common lucerne | common sowthistle | cotton thistle | creeping thistle | false star thistle | field pea | hairy vetch | hardhead thistle | heraldic thistle | holy thistle | lady's thistle | lentil | milk thistle | musk thistle | nar